Showing results (161-170 of 260) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2015
Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcomeCaroline Pical-Izard, Roberto Crocchiolo, Samuel Granjeaud, et al.
Cellular and Molecular Life Sciences : CMLS|March 2, 2015
In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activationStéphanie O Morin, Valentin Giroux, Cédric Favre, et al.
Plos One|June 9, 2017
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responsesMarta Spodzieja, Sławomir Lach, Justyna Iwaszkiewicz, et al.
AIDS Research and Therapy|April 25, 2015
Expression of activating receptors on natural killer cells from AIDS-related lymphoma patientsDelphine Mercier-Bataille, Carole Sanchez, Céline Baier, et al.
Plos One|April 29, 2009
New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosisSonia Bastonero, Yannick Le Priol, Martine Armand, et al.
Blood|September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remissionNorbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Genomics|December 12, 2003
A gene expressed exclusively in acute B lymphoblastic leukemiasAlexandra Vialle-Castellano, Sandra Laduron, Etienne De Plaen, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?Lorena Incorvaia, Giuseppe Badalamenti, Gaetana Rinaldi, et al.
Cancers|August 27, 2021
Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast CancerElie Marcheteau, Thomas Farge, Michaël Pérès, et al.
Journal of Immunology Research|June 14, 2016
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Claudia Cantoni, Leticia Huergo-Zapico, Monica Parodi, et al.
Pageof 26